Funding Opportunity RFA-MH-21-110 from the NIH Guide for Grants and Contracts. NIMH seeks applications for research projects to evaluate the effectiveness of service-ready tools and technologies that can be used to advance training, quality monitoring, and quality improvement efforts and ultimately improve the availability of evidence-based suicide prevention services. Specifically, this initiative encourages research on the effectiveness-implementation continuum aimed at (1) developing and testing the effectiveness of optimized, service-ready suicide prevention tools for identification, prevention, and treatment of individuals at risk for suicide; and (2) testing strategies to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework. Given the focus on practice-ready accessible resources and products that could be readily integrated into practice, NIMH encourages the use of technology and other design features that make the tools scalable and robust against implementation drift, and a deployment-focused approach that takes into account the perspectives of key stakeholders (e.g., service users, providers, administrators) and system-level factors, such as workforce capacity that influence potential integration of tools into clinical workflows. This FOA is intended to support effectiveness research of service-ready tools and technologies for suicide prevention that are statistically powered to provide a definitive answer regarding the study tool's effectiveness. Support for pilot effectiveness research to evaluate the initial feasibility, tolerability, acceptability, safety, and preliminary indications of effectiveness of service-ready tools and technologies for suicide prevention is provided via the R34 in RFA-21-111.Support for SBIR studies focused on service-ready tools and technologies or suicide prevention is provided via the R43/R44 in RFA-21-112.

Notice NOT-DA-21-009 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-025 from the NIH Guide for Grants and Contracts

Basic expertise in biology or bioinformatics, such as would be acquired through undergraduate courses. The researcher’s interests include ML techniques in… $13 - $19 an hour
From Indeed - Thu, 12 Nov 2020 17:20:49 GMT - View all Redmond, WA jobs

Notice NOT-DA-20-096 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-020 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-036 from the NIH Guide for Grants and Contracts. NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Notice NOT-NR-20-007 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-010 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-033 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Applicants are strongly encouraged to consult the NCI DCTD website at https://dctd.cancer.gov/ to learn more about the various program goals, research priorities, and strategies developed to fight cancer. Applications submitted to this FOA must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. Applications that propose phase III clinical trials in any area of cancer research are not sought by and will not be supported through this FOA.

Notice NOT-RM-21-008 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-006 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-002 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-RM-21-001 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Bioinformatician (Open Targets) Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Project Coordination Officer (European Genome-phenome Archive) Hinxton, Cambridgeshire, England

£50,000 - £65,000 depending on experience, plus benefits and share options: Singular Talent: How would you like to spend your time exploring genomic dark matter to find novel drug targets? Read on to learn more..... Oxford, Oxfordshire (GB)